Living-donor liver transplantation for hepatocellular carcinoma in Japan and Korea

Liver transplantation is now one of established therapeutic options for patients with hepatocellular carcinoma (HCC) and decompensated cirrhosis (1). Liver transplantation is a theoretically ideal therapeutic modality because both the tumor and the underlying disease of the liver can be treated at the same time (2).